Annual CFF
$791.49 M
+$413.51 M+109.40%
December 31, 2023
Summary
- As of March 12, 2025, LEGN annual cash flow from financing activities is $791.49 million, with the most recent change of +$413.51 million (+109.40%) on December 31, 2023.
- During the last 3 years, LEGN annual CFF has risen by +$172.61 million (+27.89%).
- LEGN annual CFF is now at all-time high.
Performance
LEGN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4.25 M
+$3.29 M+344.50%
September 30, 2024
Summary
- As of March 12, 2025, LEGN quarterly cash flow from financing activities is $4.25 million, with the most recent change of +$3.29 million (+344.50%) on September 30, 2024.
- Over the past year, LEGN quarterly CFF has increased by +$3.32 million (+358.92%).
- LEGN quarterly CFF is now -99.46% below its all-time high of $790.05 million, reached on June 30, 2023.
Performance
LEGN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$6.96 M
+$3.28 M+89.43%
September 30, 2024
Summary
- As of March 12, 2025, LEGN TTM cash flow from financing activities is $6.96 million, with the most recent change of +$3.28 million (+89.43%) on September 30, 2024.
- Over the past year, LEGN TTM CFF has dropped by -$784.53 million (-99.12%).
- LEGN TTM CFF is now -99.40% below its all-time high of $1.17 billion, reached on June 30, 2023.
Performance
LEGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LEGN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +109.4% | +358.9% | -99.1% |
| 3 y3 years | +27.9% | +358.9% | -99.1% |
| 5 y5 years | +10000.0% | +358.9% | -99.1% |
LEGN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +109.4% | -99.5% | +642.1% | -99.4% | +89.4% |
| 5 y | 5-year | at high | +5296.8% | -99.5% | +163.6% | -99.4% | +89.4% |
| alltime | all time | at high | >+9999.0% | -99.5% | +159.2% | -99.4% | +89.4% |
Legend Biotech Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.25 M(+344.5%) | $6.96 M(+89.4%) |
| Jun 2024 | - | $955.00 K(+14.9%) | $3.67 M(-99.5%) |
| Mar 2024 | - | $831.00 K(-10.2%) | $792.76 M(+0.2%) |
| Dec 2023 | $791.49 M(+109.4%) | $925.00 K(-3.7%) | $791.49 M(+0.2%) |
| Sep 2023 | - | $961.00 K(-99.9%) | $789.78 M(-32.3%) |
| Jun 2023 | - | $790.05 M(<-9900.0%) | $1.17 B(+209.0%) |
| Mar 2023 | - | -$444.00 K(-43.3%) | $377.51 M(-0.1%) |
| Dec 2022 | $377.98 M(-39.7%) | -$783.00 K(-100.2%) | $377.98 M(-46.2%) |
| Sep 2022 | - | $377.73 M(>+9900.0%) | $702.32 M(+115.6%) |
| Jun 2022 | - | $1.01 M(+3936.0%) | $325.74 M(-48.0%) |
| Mar 2022 | - | $25.00 K(-100.0%) | $626.48 M(-0.0%) |
| Dec 2021 | $626.66 M | $323.56 M(>+9900.0%) | $626.66 M(+106.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $1.14 M(-99.6%) | $303.76 M(-2.7%) |
| Jun 2021 | - | $301.75 M(>+9900.0%) | $312.28 M(-33.6%) |
| Mar 2021 | - | $207.00 K(-68.7%) | $470.33 M(-24.0%) |
| Dec 2020 | $618.88 M(+4119.8%) | $661.00 K(-93.2%) | $618.88 M(+1.2%) |
| Sep 2020 | - | $9.66 M(-97.9%) | $611.54 M(+1.6%) |
| Jun 2020 | - | $459.80 M(+209.1%) | $601.72 M(+346.6%) |
| Mar 2020 | - | $148.75 M(-2326.9%) | $134.74 M(+818.8%) |
| Dec 2019 | $14.67 M(+486.4%) | -$6.68 M(+4237.7%) | $14.67 M(-31.3%) |
| Sep 2019 | - | -$154.00 K(-97.9%) | $21.35 M(-0.7%) |
| Jun 2019 | - | -$7.18 M(-125.0%) | $21.50 M(-25.0%) |
| Mar 2019 | - | $28.68 M | $28.68 M |
| Dec 2018 | $2.50 M | - | - |
FAQ
- What is Legend Biotech annual cash flow from financing activities?
- What is the all time high annual CFF for Legend Biotech?
- What is Legend Biotech annual CFF year-on-year change?
- What is Legend Biotech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Legend Biotech?
- What is Legend Biotech quarterly CFF year-on-year change?
- What is Legend Biotech TTM cash flow from financing activities?
- What is the all time high TTM CFF for Legend Biotech?
- What is Legend Biotech TTM CFF year-on-year change?
What is Legend Biotech annual cash flow from financing activities?
The current annual CFF of LEGN is $791.49 M
What is the all time high annual CFF for Legend Biotech?
Legend Biotech all-time high annual cash flow from financing activities is $791.49 M
What is Legend Biotech annual CFF year-on-year change?
Over the past year, LEGN annual cash flow from financing activities has changed by +$413.51 M (+109.40%)
What is Legend Biotech quarterly cash flow from financing activities?
The current quarterly CFF of LEGN is $4.25 M
What is the all time high quarterly CFF for Legend Biotech?
Legend Biotech all-time high quarterly cash flow from financing activities is $790.05 M
What is Legend Biotech quarterly CFF year-on-year change?
Over the past year, LEGN quarterly cash flow from financing activities has changed by +$3.32 M (+358.92%)
What is Legend Biotech TTM cash flow from financing activities?
The current TTM CFF of LEGN is $6.96 M
What is the all time high TTM CFF for Legend Biotech?
Legend Biotech all-time high TTM cash flow from financing activities is $1.17 B
What is Legend Biotech TTM CFF year-on-year change?
Over the past year, LEGN TTM cash flow from financing activities has changed by -$784.53 M (-99.12%)